Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug development, today announced an upcoming live webinar:
“Quantitative Systems Pharmacology Modeling (QSPM) Case Study in Immuno-oncology”
to be held on Tuesday, April 12, 2016 at 11am ET/8am PT, hosted by Fierce Markets.
Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will discuss the value of QSPM approaches in drug R&D and present an industry case study in immuno-oncology. The case study entails developing and interrogating a QSPM of PD-1 and TIM-3. The QSPM provided:
- Biological insights by predicting why dosing regimens are quite similar for two therapeutics targeting PD-1 that have affinities that differ by several orders of magnitude
- Best-in-class profile predictions for PD-1 and TIM-3 dual antagonists
This webinar is ideal for scientists in R&D who want to learn more about how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs.